206 related articles for article (PubMed ID: 23046128)
1. The structural basis of HLA-associated drug hypersensitivity syndromes.
Pompeu YA; Stewart JD; Mallal S; Phillips E; Peters B; Ostrov DA
Immunol Rev; 2012 Nov; 250(1):158-66. PubMed ID: 23046128
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for self-recognition by autoimmune T-cell receptors.
Yin Y; Li Y; Mariuzza RA
Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
[TBL] [Abstract][Full Text] [Related]
3. The ternary complex: T cell receptor, MHC protein, and immunogenic peptide.
Rothbard JB
Semin Immunol; 1990 Sep; 2(5):283-95. PubMed ID: 2134014
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
5. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen-associated drug hypersensitivity.
Illing PT; Vivian JP; Purcell AW; Rossjohn J; McCluskey J
Curr Opin Immunol; 2013 Feb; 25(1):81-9. PubMed ID: 23141566
[TBL] [Abstract][Full Text] [Related]
7. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
[TBL] [Abstract][Full Text] [Related]
8. Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
Cai G; Hafler DA
Eur J Immunol; 2007 Mar; 37(3):602-12. PubMed ID: 17304631
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
Yun J; Adam J; Yerly D; Pichler WJ
Allergy; 2012 Nov; 67(11):1338-46. PubMed ID: 22943588
[TBL] [Abstract][Full Text] [Related]
10. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
Knobloch C; Goldmann SF; Friedrich W
Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
[TBL] [Abstract][Full Text] [Related]
11. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
[TBL] [Abstract][Full Text] [Related]
12. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
14. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
18. Extended repertoire of permissible peptide ligands for HLA-B*2702.
Raghavan M; Lebrón JA; Johnson JL; Bjorkman PJ
Protein Sci; 1996 Oct; 5(10):2080-8. PubMed ID: 8897608
[TBL] [Abstract][Full Text] [Related]
19. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
[TBL] [Abstract][Full Text] [Related]
20. The HLA system, antigen processing and presentation.
Krensky AM
Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]